Cavrotolimod is a toll-like receptor 9 agonist that is designed to induce anticancer immune responses through proprietary spherical nucleic acid (SNA™) technology.
Whether inherited or acquired, bleeding disorders can cause significant pain, inconvenience, and stress in a person’s life. When patients think they or a loved one may have a bleeding disorder, what should they know?
A team of investigators sought to determine outcomes from combination low-dose carboplatin plus nab-paclitaxel with concurrent radiotherapy among elderly patients with advanced non-small cell lung cancer.
A retrospective study of electronic health records sought to determine the effect of presence of diabetes on long-term outcomes for colorectal cancer survivors.
The number of genes tested for ovarian and breast cancer has grown, but most patients do not undergo testing, and variant-of-unknown-significance results are common, especially among minority populations.
Although patient-reported outcomes measures were similar with lorlatinib and crizotinib in non-small cell lung cancer, more patients reported improvement in symptoms with lorlatinib.